Efficacy and Safety of Atomoxetine Hydrochloride in Asian Adults With ADHD
- 28 July 2016
- journal article
- research article
- Published by SAGE Publications in Journal of Attention Disorders
- Vol. 21 (2) , 100-109
Abstract
Objective: The efficacy and safety of atomoxetine was assessed in adult ADHD patients from Japan, Korea, and Taiwan in this first placebo-controlled Asian clinical study in adults of an ADHD medication. Method: Atomoxetine was compared with placebo (195 atomoxetine, 196 placebo) over 10 weeks. The change from baseline to endpoint and changes over time in the Conners’ Adult ADHD Rating Scale–Investigator Rated: Screening Version total score (CAARS-Inv: SV total score) were assessed along with changes in quality of life (QoL) and executive function. Results: Atomoxetine treatment resulted in a mean reduction of −14.3 (placebo, −8.8) in CAARS-Inv: SV total score and a steady increase of between-group differences from Week 2. Improvements in QoL and executive functioning were also observed. Treatment-emergent adverse events leading to discontinuation were infrequent (atomoxetine: 5.2%, placebo: 1.5%). Conclusion: Atomoxetine was tolerable and effective in improving QoL and executive function as well as ameliorating core ADHD symptoms in adult Asian patients.Keywords
This publication has 28 references indexed in Scilit:
- A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorderInternational Journal of Neuropsychopharmacology, 2013
- An open‐label, dose‐titration tolerability study of atomoxetine hydrochloride in Japanese adults with attention‐deficit/hyperactivity disorderPsychiatry and Clinical Neurosciences, 2011
- Improvements in Executive Function Correlate with Enhanced Performance and Functioning and Health-Related Quality of Life: Evidence from 2 Large, Double-Blind, Randomized, Placebo-Controlled Trials in ADHDPostgraduate Medicine, 2010
- Atomoxetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorderDepression and Anxiety, 2009
- Once-Daily Atomoxetine for Adult Attention-Deficit/Hyperactivity DisorderJournal of Clinical Psychopharmacology, 2009
- Childhood Predictors of Adult Attention-Deficit/Hyperactivity Disorder: Results from the World Health Organization World Mental Health Survey InitiativeBiological Psychiatry, 2009
- Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspectsPharmacology & Therapeutics, 2007
- A Randomized, Double-Blind, Placebo-Controlled Clinical Trial on Once-Daily Atomoxetine Hydrochloride in Taiwanese Children and Adolescents with Attention-Deficit/Hyperactivity DisorderJournal of Child and Adolescent Psychopharmacology, 2007
- Functional Impairments in Adults With Self-Reports of Diagnosed ADHDThe Journal of Clinical Psychiatry, 2006
- Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorderPsychiatric Clinics of North America, 2004